Mallinckrodt Opioid Addiction

Woman Drinking Medicine

Overview

The Mallinckrodt opioid addiction litigation is a massive and complex legal battle centering on Mallinckrodt PLC’s significant role in the United States opioid epidemic. As one of the largest manufacturers of generic opioids, the company faced thousands of lawsuits from various entities, ultimately leading to a multi-billion dollar settlement and a Chapter 11 bankruptcy filing.

While companies like Purdue Pharma became the public face of the opioid crisis for their brand-name drugs like OxyContin, Mallinckrodt was a colossal force in the background. It was, at one point, the country’s largest manufacturer of generic opioids.

The scale of its operation was staggering. Data made public from the U.S. Drug Enforcement Administration (DEA) revealed that between 2006 and 2012, Mallinckrodt’s subsidiary, SpecGx, supplied 28.9 billion oxycodone pills in the U.S. That amount was equivalent to more than 80 pills for every person in the entire United States.

Enter Your Private Client Portal Page

Frequently Asked Questions

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

1. What is the Mallinckrodt Opioid Addiction litigation about?
The Mallinckrodt opioid addiction litigation centered on allegations that the company, one of the largest manufacturers of generic opioids in the United States, played a major role in fueling the opioid crisis through deceptive and misleading marketing. Lawsuits filed by thousands of state, local, and tribal governments alleged that Mallinckrodt downplayed the risks of addiction and aggressively pushed the widespread use of highly addictive pain medications like oxycodone. In 2022, Mallinckrodt finalized a reorganization plan following a multi-year bankruptcy that settled these claims for $1.7 billion to fund addiction treatment and abatement efforts nationwide.
2. Am I eligible to be part of this lawsuit?
Anyone who was prescribed a Mallinckrodt manufactured opioid by a medical professional and can show damages that resulted from an addiction to the medication is eligible to file a claim seeking compensation
3. What are we claiming against the defendants?
We are claiming that Mallinckrodt was aware of the risks of the opioid medication they were manufacturing, but they downplayed these risks when they aggressively marketed the drug.
4. How can I stay updated on this case?
You can stay updated by filling out our case inquiry form to receive direct email alerts regarding major milestones, court filings, and settlement updates. We will also publish key case developments directly to this website news feed.
5. How long will it take to get compensation
Every case is different and the plaintiffs are going to do everything they can to fight these claims. That said, it is not uncommon for litigation to take multiple years to reach a conclusion. We will contact you as necessary when we need documents from you. But, during the early stages of the litigation, we will focus on building the legal arguments and expert testimonies. So, it may be a while before we need your input. Please be patient while we work through these first stages.

Do You Have A Question?


Video Archives

Documents

Mallinckrodt Opioid Information

Brent Coon & Associates is representing people who became addicted to Mallinckrodt Opioids, which made generic versions of various name brand opioid drugs, most notably Roxicodone.  Although a bankruptcy plan has been proposed, the deadline to vote has not...

News Archives

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.